Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia
Clinical trial NCT01092065 · COMPLETED
Trial details
- NCT number
- NCT01092065
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-07-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.